Loading...

Bayer AG

BAYN.SG•STU
Healthcare
Drug Manufacturers - General
€28.06
€0.92(3.41%)

Bayer AG (BAYN.SG) Stock Overview

Explore Bayer AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.4/100

Key Financials

Market Cap28.7B
P/E Ratio-8.51
EPS (TTM)N/A
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$26.52
1 Month$24.44
3 Months$22.41
1 Year Target$12.95

BAYN.SG Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bayer AG (BAYN.SG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.51 and a market capitalization of 28.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;